Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians
AbstractInsomnia is a prevalent disorder with deleterious effects such as decreased quality of life, and a predisposition to a number of psychiatric disorders. Fortunately, numerous approved hypnotic treatments are available. This report reviews the state of the art of pharmacotherapy with a reference to cognitive behavioral therapy for insomnia (CBT-I) as well. It provides the clinician with a guide to all the Food and Drug Administration (FDA) approved hypnotics (benzodiazepines, nonbenzodiazepines, ramelteon, low dose sinequan, and suvorexant) including potential side effects. Frequently, chronic insomnia lasts longer than 2 years. Cognizant of this and as a result of longer-term studies, the FDA has approved all hypnotics since 2005 without restricting the duration of use. Our manuscript also reviews off-label hypnotics (sedating antidepressants, atypical antipsychotics, anticonvulsants and antihistamines) which in reality, are more often prescribed than approved hypnotics. The choice of which hypnotic to choose is discussed partially being based on which segment of sleep is disturbed and whether co-morbid illnesses exist. Lastly, we discuss recent label changes required by the FDA inserting a warning about “sleep-related complex behaviors”, e.g., sleep-driving for all hypnotics. In addition, we discuss FDA mandated dose reductions for most zolpidem preparations in women due to high zolpidem levels in the morning hours potentially causing daytime carry-over effects. View Full-Text
Share & Cite This Article
Asnis, G.M.; Thomas, M.; Henderson, M.A. Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians. Int. J. Mol. Sci. 2016, 17, 50.
Asnis GM, Thomas M, Henderson MA. Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians. International Journal of Molecular Sciences. 2016; 17(1):50.Chicago/Turabian Style
Asnis, Gregory M.; Thomas, Manju; Henderson, Margaret A. 2016. "Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians." Int. J. Mol. Sci. 17, no. 1: 50.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.